PL2465519T3 - Leczenie dysfunkcji śródbłonka u pacjentów z cukrzycą - Google Patents
Leczenie dysfunkcji śródbłonka u pacjentów z cukrzycąInfo
- Publication number
- PL2465519T3 PL2465519T3 PL11185508T PL11185508T PL2465519T3 PL 2465519 T3 PL2465519 T3 PL 2465519T3 PL 11185508 T PL11185508 T PL 11185508T PL 11185508 T PL11185508 T PL 11185508T PL 2465519 T3 PL2465519 T3 PL 2465519T3
- Authority
- PL
- Poland
- Prior art keywords
- treatment
- endothelial dysfunction
- diabetic patients
- diabetes induced
- patient
- Prior art date
Links
- 206010012601 diabetes mellitus Diseases 0.000 title abstract 4
- 206010048554 Endothelial dysfunction Diseases 0.000 title abstract 2
- 230000008694 endothelial dysfunction Effects 0.000 title abstract 2
- 102000015779 HDL Lipoproteins Human genes 0.000 abstract 2
- 108010010234 HDL Lipoproteins Proteins 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 208000035475 disorder Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000007911 parenteral administration Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07250870A EP1964571B1 (en) | 2007-03-01 | 2007-03-01 | Treatment of endothelial dysfunction in diabetic patients |
| EP11185508.6A EP2465519B1 (en) | 2007-03-01 | 2007-03-01 | Treatment of endothelial dysfunction in diabetic patients |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2465519T3 true PL2465519T3 (pl) | 2014-05-30 |
Family
ID=38124002
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL07250870T PL1964571T3 (pl) | 2007-03-01 | 2007-03-01 | leczenie dysfunkcji śródbłonka u pacjentów z cukrzycą |
| PL11185508T PL2465519T3 (pl) | 2007-03-01 | 2007-03-01 | Leczenie dysfunkcji śródbłonka u pacjentów z cukrzycą |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL07250870T PL1964571T3 (pl) | 2007-03-01 | 2007-03-01 | leczenie dysfunkcji śródbłonka u pacjentów z cukrzycą |
Country Status (5)
| Country | Link |
|---|---|
| EP (2) | EP1964571B1 (pl) |
| AT (1) | ATE555801T1 (pl) |
| DK (2) | DK2465519T3 (pl) |
| ES (2) | ES2442594T3 (pl) |
| PL (2) | PL1964571T3 (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021204878A1 (en) * | 2020-04-08 | 2021-10-14 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Use of cdon inhibitors for the treatment of endothelial dysfunction |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU6522486A (en) | 1985-10-04 | 1987-04-24 | Biotechnology Research Partners Limited | Recombinant apolipoproteins and methods |
| GB8625435D0 (en) | 1986-10-23 | 1986-11-26 | Erba Farmitalia | Human apolipoprotein ai |
| IT1229996B (it) | 1989-04-20 | 1991-09-20 | Cesare Sirtori | Espressione di apolipoproteina ai e apolipoproteina ai-milano in lievito e composizioni farmaceutiche che contengono dette apolipoproteine. |
| US5652339A (en) | 1993-12-31 | 1997-07-29 | Rotkreuzstiftung Zentrallaboratorium | Method of producing reconstituted lipoproteins |
| SE9603303D0 (sv) | 1996-09-11 | 1996-09-11 | Pharmacia & Upjohn Ab | Process for purifying a protein |
| US6004925A (en) | 1997-09-29 | 1999-12-21 | J. L. Dasseux | Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| US6037323A (en) | 1997-09-29 | 2000-03-14 | Jean-Louis Dasseux | Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| CN101189339A (zh) * | 2005-03-22 | 2008-05-28 | 美得思达健康有限公司 | 诊断和治疗心血管疾病的递送系统和方法 |
-
2007
- 2007-03-01 AT AT07250870T patent/ATE555801T1/de active
- 2007-03-01 DK DK11185508.6T patent/DK2465519T3/da active
- 2007-03-01 PL PL07250870T patent/PL1964571T3/pl unknown
- 2007-03-01 EP EP07250870A patent/EP1964571B1/en active Active
- 2007-03-01 EP EP11185508.6A patent/EP2465519B1/en active Active
- 2007-03-01 ES ES11185508.6T patent/ES2442594T3/es active Active
- 2007-03-01 DK DK07250870.8T patent/DK1964571T3/da active
- 2007-03-01 PL PL11185508T patent/PL2465519T3/pl unknown
- 2007-03-01 ES ES07250870T patent/ES2386905T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| PL1964571T3 (pl) | 2012-10-31 |
| EP2465519A1 (en) | 2012-06-20 |
| EP1964571A1 (en) | 2008-09-03 |
| ATE555801T1 (de) | 2012-05-15 |
| DK1964571T3 (da) | 2012-08-13 |
| ES2386905T3 (es) | 2012-09-05 |
| ES2442594T3 (es) | 2014-02-12 |
| EP2465519B1 (en) | 2013-10-23 |
| DK2465519T3 (da) | 2014-02-03 |
| HK1171656A1 (en) | 2013-04-05 |
| EP1964571B1 (en) | 2012-05-02 |
| HK1121938A1 (en) | 2009-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2008013304A (es) | Compuestos de peptido 1 tipo glucagon. | |
| IL184364A0 (en) | Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level | |
| IL211370A0 (en) | Treatment for diabetes in patients with insufficient glycemic control desptie therapy with an oral or non-oral antidiabetic drug | |
| MX2009010196A (es) | Administracion de oligonucleotidos antisentido complementarios para apolipoproteina humana. | |
| MY162067A (en) | Combination therapy for treatment of patients with neurological disorders and cerebral infarction | |
| WO2007120936A3 (en) | Use.of vildagliptin for the treatment of diabetes | |
| MY153062A (en) | Methods of treating gastrointestinal disorders independent of the intake of food | |
| ZA201000990B (en) | Herbal formulations for controlling blood glucose levels in patients with diabetes | |
| PL2465519T3 (pl) | Leczenie dysfunkcji śródbłonka u pacjentów z cukrzycą | |
| ZA200705470B (en) | Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level | |
| WO2007027225A3 (en) | Combination therapy for the treatment of obesity and diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level | |
| WO2008126085A3 (en) | Method for treating bone marrow disorders | |
| AR048460A1 (es) | Tratamiento de la funcion respiratoria alterada con gaboxadol | |
| TW200724189A (en) | Method of and system for predicting dose delivery | |
| UA49068U (ru) | Способ лечения больных хроническим некалькулезным| холециститом в сочетании с сахарным диабетом 2-го типа | |
| NO20085182L (no) | Behandling av tumorer hos pediatrikse pasienter med antagonister mot epidermal vekstfaktorresptor | |
| TW200738229A (en) | Memantine for the normalization of visual acuity deficits | |
| UA37078U (ru) | Способ профилактики рефлюкс-холангита при хирургическом лечении больных с механической желтухой | |
| UA39525U (ru) | Способ хирургического лечения больных остеомиелитом нижней челюсти | |
| UA46199U (ru) | Способ коррекции нарушений реологических свойств крови у больных хроническим обструктивным заболеванием легких, сочетанным с гипертонической болезнью и инсулинорезистентностью | |
| UA29556U (ru) | Способ лечения больных острыми вирусными менингитами | |
| HK1107939A (en) | Combination therapy for the treatment of obesity and diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level | |
| UA33212U (ru) | Способ коррекции метаболических нарушений у больных с синдромом повышенной усталости на фоне хронического тонзиллита | |
| UA35025U (ru) | Способ коррекции метаболических нарушений у больных с метаболическим синдромом | |
| SG146498A1 (en) | Compositions for treatment of patients with neurological disorders and cerebral infarction |